Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis.
Yoshinori FujitaYujiro FukudaFumiaki SanukiIsao IreiYasumasa MonobeMasako UnoTakeshi AkisadaKoichiro ShimoyaHirotaka HaraTakuya MoriyaPublished in: Head and neck pathology (2023)
Our results suggest that PAR1 expression affects the prognosis and recurrence rate of HPV-associated oropharyngeal cancer.